Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	6,019	4,099	1,991	1,379	709	488
Market Cap Growth	166.67%	105.94%	44.32%	94.55%	45.34%	-6.17%
Enterprise Value	5,847	4,033	2,026	1,400	558.49	333.15
Last Close Price	98.71	78.99	41.35	29.52	19.50	15.95
PS Ratio	10.38	7.86	5.91	7.40	9.20	25.49
PB Ratio	24.45	13.03	8.82	5.55	4.99	4.06
P/TBV Ratio	22.09	12.60	8.71	4.85	4.67	4.02
P/FCF Ratio	-	74.71	213.30	-	-	-
P/OCF Ratio	-	73.43	192.79	-	-	-
EV/Sales Ratio	10.27	7.74	6.01	7.51	7.25	17.41
EV/EBITDA Ratio	-	1913.32	-	-	-	-
EV/FCF Ratio	-	73.50	217.13	-	-	-
Debt / Equity Ratio	1.33	1.01	1.40	1.23	0.01	0.02
Debt / EBITDA Ratio	-	150.53	-	-	-	-
Debt / FCF Ratio	-	5.78	33.87	-	-	-
Net Debt / Equity Ratio	-0.27	-0.21	0.16	0.09	-1.05	-1.28
Net Debt / EBITDA Ratio	0.08	-31.32	-0.56	-0.22	1.17	0.89
Net Debt / FCF Ratio	0.38	-1.20	3.83	-0.31	1.24	1.16
Asset Turnover	0.47	0.69	0.51	0.37	0.24	0.07
Inventory Turnover	4.21	4.24	3.65	3.37	3.50	2.52
Quick Ratio	1.90	2.46	2.83	4.07	2.71	3.75
Current Ratio	2.09	2.67	3.10	4.45	2.94	3.91
Return on Equity (ROE)	-286.74%	-8.65%	-37.08%	-83.65%	-103.46%	-57.47%
Return on Assets (ROA)	-92.03%	-3.19%	-13.46%	-21.97%	-38.70%	-64.79%
Return on Invested Capital (ROIC)	-312.05%	-9.33%	-32.94%	-53.21%	-105.88%	-382.54%
Return on Capital Employed (ROCE)	-126.91%	-3.75%	-15.87%	-25.75%	-48.58%	-73.10%
FCF Yield	-	1.34%	0.47%	-	-	-
Buyback Yield / Dilution	-9.74%	-5.63%	-16.23%	-20.31%	-12.07%	-20.08%
Total Shareholder Return	-9.74%	-5.63%	-16.23%	-20.31%	-12.07%	-20.08%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q